COVID-19 treatment

February 7, 2022

Study shows lifesaving benefit of baricitinib for ventilated COVID patients

Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

By Craig Boerner
The virtual Advanced Practice Grand Rounds focused on the experience of caring for COVID-19 patients for nearly two years.
February 3, 2022

Advanced Practice Grand Rounds explores COVID’s impact

The recent VUMC Advanced Practice Grand Rounds explored the impact the ongoing COVID-19 pandemic is having on the nursing workforce.

By Matt Batcheldor
January 20, 2022

Omicron evades some but not all monoclonal antibodies: study

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.

By Bill Snyder
December 24, 2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.

By Tom Wilemon
Cody Stubblefield, RN, gives the first of two injections of an antibody combination to Caroline Davis to protect her from COVID-19.
December 23, 2021

Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness

On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.

By Bill Snyder
PHOTO: Members of the supermere discovery team include (front row from left) Qi Liu, PhD, Robert Coffey, MD, Qin Zhang, PhD, and (back row from left) James Higginbotham, PhD; Dennis Jeppesen, PhD; and Jeffrey Franklin, PhD. (hoto by Erin O. Smith)
December 10, 2021

“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

By Bill Snyder
December 9, 2021

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.
By Bill Snyder
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
November 19, 2021

A death or serious injury of a parent can mean a scared and bewildered child. Arielle Silverman helps children understand and cope.

She has worked with children varying in age from under 2 years old to teenagers as old as 18.
By Wayne Wood
November 11, 2021

VUMC tests drugs for COVID outpatient treatment

By Paul Govern
November 11, 2021

Translational Research Forum honors scientific excellence

Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum
By Bill Snyder
October 21, 2021

Study explores impact of COVID-19 on children

By Jessica Pasley
October 5, 2021

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.
By Bill Snyder
1 2 3 4 5 … 11